Moderna begins testing on children: What you need to know
Moderna on Tuesday started testing its vaccine for COVID-19 on children. Moderna’s vaccine is a two-dose vaccine, administered 28 days apart. Here is everything we know about the trial:
The company said that they plan to enroll around 6750 children in the United States and Canada to begin the trials.
The ages of the children will be between 6 months and 12 years.
For children between 12 and 18, there is already a study in progress conducted by Modern which started in December last year.
Both in the United States and Canada, currently, there is no vaccine available for children younger than 16.
The Pfizer-BioNTech vaccine can be used in anyone 16 and older.